Understanding Non-Hodgkin’s Lymphoma ICD-10 Codes: A Comprehensive Guide

Non-Hodgkin’s Lymphoma ICD-10

Non-Hodgkin’s lymphoma is a type of cancer that originates in the lymphatic system, which is a part of the body’s immune system. This type of cancer is different from Hodgkin’s lymphoma, which is another form of lymphoma that is characterized by the presence of Reed-Sternberg cells. Non-Hodgkin’s lymphoma can affect various parts of the body, including the lymph nodes, spleen, bone marrow, and other organs.

Code Information

The ICD-10 code for non-Hodgkin’s lymphoma is C82.9. This code is used to classify and code diagnoses related to non-Hodgkin’s lymphoma in medical records and billing purposes. It is important to use the correct code for accurate documentation and reimbursement.

Diagnostic Related Groups (MS-DRG)

Non-Hodgkin-Lymphom – Wikipedia
Non-Hodgkin-Lymphom – Wikipedia

Non-Hodgkin’s lymphoma is classified under MS-DRG 834 – Lymphoma and Non-Acute Leukemia with Major Operating Room Procedure. This DRG is used to group and categorize patients with similar diagnoses and medical procedures for the purpose of reimbursement and resource allocation.

Convert to ICD-9 Code

The equivalent ICD-9 code for non-Hodgkin’s lymphoma is 200.00. This code was used prior to the implementation of ICD-10 coding system and is still sometimes referenced in medical records and databases.

Code History

ICD--CM Diagnosis Code C
ICD–CM Diagnosis Code C

The ICD-10 code for non-Hodgkin’s lymphoma, C82.9, was adopted by the World Health Organization (WHO) in 1994 as part of the 10th revision of the International Classification of Diseases. This code has since been widely used in healthcare settings around the world to classify and code cases of non-Hodgkin’s lymphoma.

Approximate Synonyms

Non-Hodgkin’s lymphoma is also known by other names and terms, including non-Hodgkin lymphoma, NHL, lymphoma, and lymphosarcoma. These terms may be used interchangeably in medical literature and discussions about the disease.

Clinical Information

Non-Hodgkin’s lymphoma is a heterogeneous group of lymphoid malignancies that arise from B cells, T cells, or natural killer (NK) cells. The disease can present with a wide range of clinical manifestations, including painless lymph node enlargement, fever, night sweats, weight loss, and fatigue. Diagnosis and classification of non-Hodgkin’s lymphoma are based on histopathological examination of tissue samples and immunophenotyping studies.


The exact cause of non-Hodgkin’s lymphoma is not well understood, but several risk factors have been identified. These include age, immune system deficiencies, certain infections (such as Epstein-Barr virus and human immunodeficiency virus), exposure to certain chemicals and radiation, and genetic factors. It is believed that a combination of genetic and environmental factors contributes to the development of non-Hodgkin’s lymphoma.


Common symptoms of non-Hodgkin’s lymphoma include painless swelling of lymph nodes in the neck, armpits, or groin, unexplained fever, night sweats, fatigue, and weight loss. Other symptoms may include itching, respiratory symptoms, abdominal pain, and neurological symptoms. The presence and severity of symptoms may vary depending on the type and stage of the disease.


Diagnosis of non-Hodgkin’s lymphoma is based on a combination of clinical evaluation, imaging studies (such as CT scans and PET scans), blood tests, and biopsy of lymph nodes or other affected tissues. Histopathological examination and immunophenotyping of tissue samples are essential for accurate diagnosis and classification of the disease.


Treatment of non-Hodgkin’s lymphoma depends on the type, stage, and aggressiveness of the disease, as well as the patient’s overall health and preferences. Common treatment modalities include chemotherapy, radiation therapy, targeted therapy, immunotherapy, and stem cell transplantation. The goal of treatment is to eradicate cancer cells, induce remission, and improve quality of life for patients.


Non-Hodgkin’s lymphoma is a complex and diverse group of cancers that arise from the lymphatic system. Accurate diagnosis, classification

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button